Physician profile
Perry Cain
NPI 1649257528
$1,783.26
in general payments reported to CMS, 2019-2025
9 companies · $454 in 2025
The $454 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $198 · 2022: $101 · 2023: $203 · 2024: $828 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,484.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $519.74 | 2023-2025 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $338.94 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $295.19 | 2021-2025 | Jardiance, Synjardy, Spiriva |
| Astrazeneca Pharmaceuticals LP | $286.39 | 2024-2025 | Lokelma |
| Amarin Pharma, INC. | $126.49 | 2021-2023 | |
| Astellas Pharma US INC | $95.59 | 2021-2022 | |
| Glaxosmithkline, LLC. | $79.75 | 2024-2025 | Trelegy Ellipta, Arexvy |
| Medtronic, INC. | $23.70 | 2023 | Interstim |
| Kowa Pharmaceuticals America, INC. | $17.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perry Cain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.